POMT1 and muscular dystrophy-dystroglycanopathy: POMT1 was reported to be important in a series of metabolic diseases called muscular dystrophy-dystroglycanopathies (MDDGs), accompanied by variable degrees of intellectual disability, with brain and ocular abnormalities [18].